The COVID-19 pandemic has put an unprecedented burden on healthcare systems worldwide. This has hampered the management of several highly prevalent clinical conditions in the country, including diabetes, cancer, and coronary heart diseases.
Very little is known about the pandemic’s effects on the management of acute coronary syndrome (ACS).